[1]
“Clinical audit: Baseline investigations for intramuscular meglumine antimoniate in cases of cutaneous leishmaniasis”, J Pak Assoc Dermatol, vol. 23, no. 1, pp. 67–70, Dec. 2016, doi: 10.66344/jpad.v23i1.264.